Morningstar

T2 Biosystems Inc TTOO

Morningstar Rating

T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture

GlobeNewswire Sep 23, 2024 1:00pm
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union

GlobeNewswire Sep 20, 2024 1:00pm
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients

GlobeNewswire Sep 16, 2024 1:00pm
T2 Biosystems Provides Updates on its New Product Development Pipeline Progress

GlobeNewswire Sep 9, 2024 1:00pm
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire Aug 27, 2024 8:05pm
Sidoti Events, LLC's Virtual August Micro-Cap Conference

Accesswire Aug 13, 2024 1:30pm
T2 Biosystems to Attend Upcoming Investor Conferences

GlobeNewswire Aug 1, 2024 8:05pm
T2 Biosystems Announces Second Quarter 2024 Financial Results

GlobeNewswire Jul 29, 2024 8:05pm
T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor

GlobeNewswire Jul 29, 2024 8:02pm
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024

GlobeNewswire Jul 22, 2024 8:05pm
T2 Biosystems Gets 510(k) Clearance For Expanded T2Bacteria Panel

Global News Select Feb 12, 2024 2:28pm
T2 Biosystems reaches regulatory milestone that could be a game changer, analyst says

MarketWatch Sep 21, 2023 11:29am
T2 Biosystems' stock extends losing streak despite FDA approval for anthrax and plague diagnostic test

MarketWatch Sep 20, 2023 8:50pm

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2024 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.